For removal of DOACs from plasma specimens
Laboratories using direct oral anticoagulants (DOACs) for diagnostics purposes often face problems, since the presence of DOACs in human citrated plasma samples interfere with various clotting tests. DOAC-Remove™ tablets are intended to be used for removal of DOACs from human citrated plasma samples:
- One tablet of DOAC-Remove neutralizes the influence of DOACs in 0.5 to 2 mL citrated plasma sample.
- After centrifugation, neutralized plasma supernatant can immediately be used for clotting tests such as APTT, TT, single factors, lupus AC and APC-R or it can be frozen respectively.
- No significant effect on clotting factors.
- DOAC-Remove presentations: